Dilated cardiomyopathy: Difference between revisions

Line 8: Line 8:
**Familial dilated cardiomyopathy
**Familial dilated cardiomyopathy
**Hypertensive dilated cardiomyopathy
**Hypertensive dilated cardiomyopathy
**Toxic (EtOH/beriberi, [[cocaine]], meth, chemo, heavy metals)
**Toxic ([[ETOH]]/[[beriberi]], [[cocaine]], [[methamphetamine]], chemo, [[heavy metals]])
**[[Hyperthyroidism]]
**[[Hyperthyroidism]]
**[[Sarcoidosis]]
**[[Sarcoidosis]]
Line 17: Line 17:
**Infiltrative disease
**Infiltrative disease
**Mitochondrial disease
**Mitochondrial disease
**Tachycardia-mediated
**[[Tachycardia]]-mediated
**ESRD
**[[ESRD]]
**Eosinophilic (Churg Strauss)
**Eosinophilic ([[Churg-Strauss syndrome]])


==Evaluation==
==Evaluation==

Revision as of 18:49, 24 September 2019

Background

Evaluation

  • CHF symptoms
  • CXR
    • Cardiomegaly, pulmonary venous htn
  • ECG
    • LV hypertrophy, poor R wave progression
  • Ultrasound
    • Bedside (for gross function)
    • TTE/TEE for EF

Differential Diagnosis

Cardiomyopathy

Management

  • Treat the underlying diseae
  • Similar to CHF exacerbation
  • Ensure exacerbation not due to ischemia

See Also

References